Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Type
- Observational
- Design
- Observational Model: OtherTime Perspective: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Observational Study Model = Other [non-treatment; impact on external location (rooms and surfaces)] Time Perspective = Other [viral load samples taken at various time points after nebulization or MDI administered] Sampling Method = Non-probability sample [to be described by study team]
Observational Study Model = Other [non-treatment; impact on external location (rooms and surfaces)] Time Perspective = Other [viral load samples taken at various time points after nebulization or MDI administered] Sampling Method = Non-probability sample [to be described by study team]
Tracking Information
- NCT #
- NCT04681079
- Collaborators
- Not Provided
- Investigators
- Study Director: Medical Monitor Theravance Biopharma